Trutino Biosciences Inc.
1 clinical trials · Sponsor
◉ Watch Trutino Biosciences Inc.
| Record | Firm | Date |
|---|---|---|
| Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors (NCT06770764) | Trutino Biosciences Inc. | 2024-12-30 |
Track Trutino Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.